nilotinib dihydrate dichloride

Italy

Drugs containing this active substance

  • NILOTINIB EG

    It is used for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in adult and pediatric patients, both for a new diagnosis and for cases where previous treatments are no longer effective or have caused serious side effects.

    Form: capsules, hard gelatin

    Active substance Dosage
    nilotinib dihydrate dichloride -

    ATC: L01EA03

    Manufacturer: EG S.P.A.

  • NILOTINIB MYLAN

    It is used for the treatment of a type of leukemia called Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in adult and pediatric patients, both for new diagnoses and for those who no longer benefit from other treatments or have experienced severe side effects with them.

    Form: capsules, hard gelatin

    Active substance Dosage
    nilotinib dihydrate dichloride -

    ATC: L01EA03

    Manufacturer: MYLAN S.P.A.

  • NILOTINIB TEVA

    It is used for the treatment of a type of leukemia called Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML), in both adult and pediatric patients.

    Form: capsules, hard gelatin

    Active substance Dosage
    nilotinib dihydrate dichloride -

    ATC: L01EA03

    Manufacturer: TEVA ITALIA S.R.L.